• Khulmanee T., Thita T., Kritsiriwutinan K., Boonyuen U., Saai A., Inkabjan K., Chakrabarti R., Rathod P.K., Krudsood S., Mungthin M., Patrapuvich R. Low Genetic Diversity of Plasmodium vivax Circumsporozoite Surface Protein in Clinical Isolates from Southern Thailand. (2024) Tropical Medicine and Infectious Disease, 9 (5), art. no. 94.
• Kotepui K.U., Mahittikorn A., Wilairatana P., Masangkay F.R., Kotepui M. A systematic review and meta-analysis of the relationship between magnesium levels and malaria severity. (2024) Scientific Reports, 14 (1), art. no. 1348.
• Kotepui M., Mahittikorn A., Wilairatana P., Masangkay F.R., Wangdi K., Kotepui K.U. Methemoglobin levels in malaria: a systematic review and meta-analysis of its association with Plasmodium falciparum and Plasmodium vivax infections and disease severity. (2024) Scientific Reports, 14 (1), art. no. 3276.
• Kuraeiad S., Kotepui K.U., Mahittikorn A., Masangkay F.R., Wilairatana P., Suwannatrai A.T., Thinkhamrop K., Wangdi K., Kotepui M. Albumin levels in malaria patients: a systematic review and meta-analysis of their association with disease severity. (2024) Scientific Reports, 14 (1), art. no. 10185.
• Singhasenee P., Tangpukdee N., Krudsood S., Lawpoolsri S., Chancharoenthana W., Matsee W., Wilairatana P. Factors associated with severe Plasmodium vivax malaria: A 15-year retrospective study. Southeast Asian J Trop Med Public Health. 2024;55(3):105-135.
• Wongsawat M., Glaharn S., Srisook C., Dechkhajorn W., Chaisri U., Punsawad C., Techarang T., Chotivanich K., Krudsood S., Viriyavejakul P. Immunofluorescence study of cytoskeleton in endothelial cells induced with malaria sera. (2024) Malaria Journal, 23 (1), art. no. 10

Duangdee C., Tangpukdee N., Sukphopetch P., Maneekan P., Sangmukdanun S., Krudsood S., Wilairatana P.  Human b-defensin 1 in patients with Plasmodium falciparum malaria.  Kariri Science-CECAPE Biology and Health Journal v.1 n.1.  2023;3-8.

Kotepui K.U., Mahittikorn A., Wilairatana P., Masangkay F.R., Kotepui M.  The Association between Malaria and β-Carotene Levels: A Systematic Review and Meta-Analysis.  (2023) Antioxidants, 12 (9), art. no. 1687

Kotepui K.U., Mahittikorn A., Wilairatana P., Masangkay F.R., Kotepui M.  A Systematic Review and Meta-Analysis Exploring Variations in Copper Levels between Individuals with Malaria and Uninfected Controls.  (2023) Nutrients, 15 (22), art. no. 4749.

Kotepui K.U., Mahittikorn A., Wilairatana P., Masangkay F.R., Kotepui M.  Regional and Age-Related Variations in Blood Calcium Levels among Patients with Plasmodium falciparum and P. vivax malaria: A Systematic Review and Meta-Analysis.  (2023) Nutrients, 15 (21), art. no. 4522.

Kotepui M., Kotepui K.U., Masangkay F.R., Wilairatana P.  Evidence of malarial chemoprophylaxis among travellers who died from malaria: a systematic review and meta-analysis.  (2023) Malaria Journal, 22 (1), art. no. 359.

Kotepui M., Mala W., Kwankaew P., Kotepui K.U., Masangkay F.R., Wilairatana P.  Distinct cytokine profiles in malaria coinfections: A systematic review.  (2023) PLoS Neglected Tropical Diseases, 17 (1), art. no. e0011061.

Kotepui M., Wilairatana P., Mala W., Kotepui K.U., Masangkay F.R., Wangdi K.  Effects of Daily Zinc Alone or in Combination with Other Nutrient Supplements on the Risk of Malaria Parasitaemia: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.  (2023) Nutrients, 15 (13), art. no. 2855. 

Looareesuwan P., Krudsood S., Lawpoolsri S., Tangpukdee N., Matsee W., Nguitragool W., Wilairatana P.  Gametocyte prevalence and risk factors of P. falciparum malaria patients admitted at the Hospital for Tropical Diseases, Thailand: a 20-year retrospective study.  (2023) Malaria Journal, 22 (1), art. no. 321.

Sornsenee P., Wilairatana P., Kotepui K.U., Masangkay F.R., Romyasamit C., Kotepui M.  Relation between Increased IL-10 Levels and Malaria Severity: A Systematic Review and Meta-Analysis.  (2023) Tropical Medicine and Infectious Disease, 8 (1), art. no. 35.

Tangpukdee N., Wilairatana P., Kano S., Krudsood S.  ANTIMALARIAL DRUG TOXICITY: AN UPDATED BRIEF REVIEW.  (2023) Southeast Asian Journal of Tropical Medicine and Public Health, 54 (6), pp. 403 – 424.

Adam I., Alam M.S., Alemu S., Amaratunga C., Amato R., Andrianaranjaka V., Anstey N.M., Aseffa A., Ashley E., Assefa A., Auburn S., Barber B.E., Barry A., Batista Pereira D., Cao J., Chau N.H., Chotivanich K., Chu C., Dondorp A.M., Drury E., Echeverry D.F., Erko B., Espino F., Fairhurst R., Faiz A., Fernanda Villegas M., Gao Q., Golassa L., Goncalves S., Grigg M.J., Hamedi Y., Hien T.T., Htut Y., Johnson K.J., Karunaweera N., Khan W., Krudsood S., Kwiatkowski D.P., Lacerda M., Ley B., Lim P., Liu Y., Llanos-Cuentas A., Lon C., Lopera-Mesa T., Marfurt J., Michon P., Miotto O., Mohammed R., Mueller I., Namaik-larp C., Newton P.N., Nguyen T.-N., Nosten F., Noviyanti R., Pava Z., Pearson R.D., Petros B., Phyo A.P., Price R.N., Pukrittayakamee S., Rahim A.G., Randrianarivelojosia M., Rayner J.C., Rumaseb A., Siegel S.V., Simpson V.J., Thriemer K., Tobon-Castano A., Trimarsanto H., Urbano Ferreira M., Vélez I.D., Wangchuk S., Wellems T.E., White N.J., William T., Yasnot M.F., Yilma D.  An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.  (2022) Wellcome Open Research, 7, art. no. 136

Chamchoy K., Sudsumrit S., Thita T., Krudsood S., Patrapuvich R., Boonyuen U.  Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure.  (2022) PLoS Neglected Tropical Diseases, 16 (12), art. no. e0010986

Mahittikorn A., Kotepui K.U., Mala W., Wilairatana P., Kotepui M.  Procalcitonin as a Candidate Biomarker for Malarial Infection and Severe Malaria: A Meta-Analysis.  (2022) International Journal of Environmental Research and Public Health, 19 (18), art. no. 11389.

Mahittikorn A., Mala W., Masangkay F.R., Kotepui K.U., Wilairatana P., Kotepui M.  Author Correction: Increased interferon-γ levels and risk of severe malaria: a meta-analysis (Scientific Reports, (2022), 12, 1, (18917), 10.1038/s41598-022-21965-z).  (2022) Scientific Reports, 12 (1), art. no. 21370

Mahittikorn A., Mala W., Masangkay F.R., Kotepui K.U., Wilairatana P., Kotepui M.  Increased interferon-γ levels and risk of severe malaria: a meta-analysis.  (2022) Scientific Reports, 12 (1), art. no. 18917.

Mahittikorn A., Mala W., Srisuphanunt M., Masangkay F.R., Kotepui K.U., Wilairatana P., Kotepui M.  Tumour necrosis factor-α as a prognostic biomarker of severe malaria: a systematic review and meta-analysis.  (2022) Journal of Travel Medicine, 29 (4), art. no. taac053.

Mahittikorn A., Mala W., Wilairatana P., Siri S., Masangkay F.R., Kotepui K.U., Kotepui M.  Prevalence, anti-malarial chemoprophylaxis and causes of deaths for severe imported malaria: A systematic review and meta-analysis.  (2022) Travel Medicine and Infectious Disease, 49, art. no. 102408. 

Mala W., Wilairatana P., Milanez G.D.J., Masangkay F.R., Kotepui K.U., Kotepui M.  Evidence of and deaths from malaria and severe pneumonia co-infections in malaria-endemic areas: a systematic review and meta-analysis.  (2022) Scientific Reports, 12 (1), art. no. 17344.

Mala W., Wilairatana P., Samerjai C., Masangkay F.R., Kotepui K.U., Kotepui M.  Prevalence of Signs of Severity Identified in the Thai Population with Malaria: A Systematic Review and Meta-Analysis.  (2022) International Journal of Environmental Research and Public Health, 19 (3), art. no. 1196.

Mala W., Wilairatana P., Wattanapisit A., Kotepui K.U., Kotepui M.  Malaria Publications before and during COVID-19 Pandemic: A Bibliometric Analysis.  (2022) Publications, 10 (3), art. no. 28.

Mon N.T.S., Tangpukdee N., Charunwatthana P., Boonnak K., Krudsood S., Kano S., Wilairatana P., Leowattana W.  Mimicking platelet indices in patients with malaria and dengue hemorrhagic fever: characteristics and clinical applications.  (2022) Tropical Medicine and Health, 50 (1), art. no. 76.

Mungkalasut P., Kiatamornrak P., Jugnam-Ang W., Krudsood S., Cheepsunthorn P., Cheepsunthorn C.L.  Haematological profile of malaria patients with G6PD and PKLR variants (erythrocytic enzymopathies): a cross-sectional study in Thailand.  (2022) Malaria Journal, 21 (1), art. no. 250.

Sudsumrit S., Chamchoy K., Songdej D., Adisakwattana P., Krudsood S., Adams E.R., Imwong M., Leartsakulpanich U., Boonyuen U.  Genotype-phenotype association and biochemical analyses of glucose-6-phosphate dehydrogenase variants: Implications for the hemolytic risk of using 8-aminoquinolines for radical cure.  (2022) Frontiers in Pharmacology, 13, art. no. 1032938

Trimarsanto H., Amato R., Pearson R.D., Sutanto E., Noviyanti R., Trianty L., Marfurt J., Pava Z., Echeverry D.F., Lopera-Mesa T.M., Montenegro L.M., Tobón-Castaño A., Grigg M.J., Barber B., William T., Anstey N.M., Getachew S., Petros B., Aseffa A., Assefa A., Rahim A.G., Chau N.H., Hien T.T., Alam M.S., Khan W.A., Ley B., Thriemer K., Wangchuck S., Hamedi Y., Adam I., Liu Y., Gao Q., Sriprawat K., Ferreira M.U., Laman M., Barry A., Mueller I., Lacerda M.V.G., Llanos-Cuentas A., Krudsood S., Lon C., Mohammed R., Yilma D., Pereira D.B., Espino F.E.J., Chu C.S., Vélez I.D., Namaik-larp C., Villegas M.F., Green J.A., Koh G., Rayner J.C., Drury E., Gonçalves S., Simpson V., Miotto O., Miles A., White N.J., Nosten F., Kwiatkowski D.P., Price R.N., Auburn S.  A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria.  (2022) Communications Biology, 5 (1), art. no. 1411

Wilairatana P., Kotepui K.U., Mala W., Wangdi K., Kotepui M.  Prevalence, probability, and characteristics of malaria and filariasis co-infections: A systematic review and meta-analysis.  (2022) PLoS Neglected Tropical Diseases, 16 (10), art. no. e0010857.

Wilairatana P., Kwankaew P., Kotepui K.U., Kotepui M.  Low Interleukin-12 Levels concerning Severe Malaria: A Systematic Review and Meta-Analysis.  (2022) International Journal of Environmental Research and Public Health, 19 (15), art. no. 9345.

Wilairatana P., Mala W., Kotepui K.U., Kotepui M.  Prevalence and Characteristics of Malaria and Influenza Co-Infection in Febrile Patients: A Systematic Review and Meta-Analysis.  (2022) Tropical Medicine and Infectious Disease, 7 (8), art. no. 168.

Wilairatana P., Mala W., Masangkay F.R., Kotepui K.U., Kotepui M.  The Prevalence of Malaria and Bacteremia Co-Infections among Febrile Patients: A Systematic Review and Meta-Analysis.  (2022) Tropical Medicine and Infectious Disease, 7 (9), art. no. 243

Wilairatana P., Mala W., Milanez G.D.J., Masangkay F.R., Kotepui K.U., Kotepui M.  Increased interleukin-6 levels associated with malaria infection and disease severity: a systematic review and meta-analysis.  (2022) Scientific Reports, 12 (1), art. no. 5982.

Wilairatana P., Masangkay F.R., Kotepui K.U., De Jesus Milanez G., Kotepui M.  Prevalence and risk of Plasmodium vivax infection among Duffy-negative individuals: a systematic review and meta-analysis.  (2022) Scientific Reports, 12 (1), art. no. 3998.

Mahittikorn A., Masangkay F.R., Kotepui K.U., Mala W., Milanez G.J., Wilairatana P., Kotepui M.  Alteration of platelet count in patients with severe non-plasmodium falciparum malaria: A systematic review and meta-analysis.  (2021) Biology, 10 (12), art. no. 1275. 

Mala W., Wilairatana P., Kotepui K.U., Kotepui M.  Prevalence of malaria and chikungunya co-infection in febrile patients: A systematic review and meta-analysis.  (2021) Tropical Medicine and Infectious Disease, 6 (3), art. no. 119.

Sivakorn C., Wilairatana P., Krudsood S., Schultz M.J., Techarang T., Kheawsawaung K., Dondorp A.M.  Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.  (2021) Malaria Journal, 20 (1), art. no. 28.

Wilairatana P., Chanmol W., Rattaprasert P., Masangkay F.R., Milanez G.D.J., Kotepui K.U., Kotepui M.  Prevalence and characteristics of malaria co-infection among individuals with visceral leishmaniasis in Africa and Asia: a systematic review and meta-analysis.  (2021) Parasites and Vectors, 14 (1), art. no. 545.

Wilairatana P., Kuraeiad S., Rattaprasert P., Kotepui M.  Prevalence of malaria and scrub typhus co-infection in febrile patients: a systematic review and meta-analysis.  (2021) Parasites and Vectors, 14 (1), art. no. 471.

Wilairatana P., Mahannop P., Tussato T., Hayeedoloh I.-M., Boonhok R., Klangbud W.K., Mala W., Kotepui K.U., Kotepui M.  C-reactive protein as an early biomarker for malaria infection and monitoring of malaria severity: a meta-analysis.  (2021) Scientific Reports, 11 (1), art. no. 22033.

Wilairatana P., Mala W., Klangbud W.K., Kotepui K.U., Rattaprasert P., Kotepui M.  Prevalence, probability, and outcomes of typhoidal/non-typhoidal Salmonella and malaria co-infection among febrile patients: a systematic review and meta-analysis.  (2021) Scientific Reports, 11 (1), art. no. 21889. 

Wilairatana P., Mala W., Kotepui M., Kotepui K.U.  Alteration of blood lactate levels in severe falciparum malaria: A systematic review and meta-analysis.  (2021) Biology, 10 (11), art. no. 1085.

Wilairatana P., Mala W., Rattaprasert P., Kotepui K.U., Kotepui M.  Prevalence of malaria and leptospirosis co-infection among febrile patients: A systematic review and meta-analysis.  (2021) Tropical Medicine and Infectious Disease, 6 (3), art. no. 122. 

Wilairatana P., Masangkay F.R., Kotepui K.U., Milanez G.J., Kotepui M.  Prevalence and characteristics of malaria among covid-19 individuals: A systematic review, meta-analysis, and analysis of case reports.  (2021) PLoS Neglected Tropical Diseases, 15 (10), art. no. e0009766.

Klinkhamhom A., Glaharn S., Srisook C., Ampawong S., Krudsood S., Ward S.A., Viriyavejakul P.  M1 macrophage features in severe Plasmodium falciparum malaria patients with pulmonary oedema.  (2020) Malaria journal, 19 (1), pp. 182. 

St Jean P.L., Koh G.C.K.W., Breton J.J., Espino F.E.J., Hien T.T., Krudsood S., Lacerda M.V.G., Llanos-Cuentas A., Lon C., Mohammed R., Namaik-Larp C.S., Pereira D.B., Saunders D.L., Velez I.D., Yilma D., Villegas M.F., Duparc S., Green J.A.  Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria.  (2020) Pharmacogenetics and Genomics, 30 (7), pp. 161 – 165.

Bonito B., Wilairatana P., Tangpukdee N., Muangnoicharoen S., Poovorawan K., Krudsood S.  Prevalence of glucose-6-phosphate dehydrogenase deficiency among vivax malaria patients at the hospital for tropical diseases, Thailand.  (2019) Southeast Asian Journal of Tropical Medicine and Public Health, 50 (2), pp. 211 – 216.

Lacerda M.V.G., Llanos-Cuentas A., Krudsood S., Lon C., Saunders D.L., Mohammed R., Yilma D., Pereira D.B., Espino F.E.J., Mia R.Z., Chuquiyauri R., Val F., Casapía M., Monteiro W.M., Brito M.A.M., Costa M.R.F., Buathong N., Noedl H., Diro E., Getie S., Wubie K.M., Abdissa A., Zeynudin A., Abebe C., Tada M.S., Brand F., Beck H.-P., Angus B., Duparc S., Kleim J.-P., Kellam L.M., Rousell V.M., Jones S.W., Hardaker E., Mohamed K., Clover D.D., Fletcher K., Breton J.J., Ugwuegbulam C.O., Green J.A., Koh G.C.K.W.  Single-dose tafenoquine to prevent relapse of plasmodium vivax malaria.  (2019) New England Journal of Medicine, 380 (3), pp. 215 – 228.

Moe J., Wilairatana P., Tangpukdee N., Muangnoicharoen S., Poovorawan K., Krudsood S.  Changes in efficacy of artemisinin-combination therapies in uncomplicated falciparum Malaria patients in Thailand: A 10-year study.  (2019) Southeast Asian Journal of Tropical Medicine and Public Health, 50 (3), pp. 433 – 441.

Oggungwan K., Glaharn S., Ampawong S., Krudsood S., Viriyavejakul P.  FTY720 restores endothelial cell permeability induced by malaria sera.  (2018) Scientific Reports, 8 (1), art. no. 10959

Para S., Mungkalasut P., Chanda M., Nuchprayoon I., Krudsood S., Cheepsunthorn C.L.  An observational study of the effect of hemoglobinopathy, alpha thalassemia and hemoglobin E on P. vivax parasitemia.  (2018) Mediterranean Journal of Hematology and Infectious Diseases, 10 (1), art. no. e2018015.

Singhasivanon O.-U., Lawpoolsri S., Mungthin M., Yimsamran S., Soonthornworasiri N., Krudsood S.  Prevalence and Alternative Treatment of Head-Lice Infestation in Rural Thailand: A Community-Based Study.  (2019) Korean Journal of Parasitology, 57 (5), pp. 499 – 504.

Warrasak S., Euswas A., Fukuda M.M., Ittiverakul M., Miller R.S., Krudsood S., Ohrt C.  Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure.  (2019) International Ophthalmology, 39 (8), pp. 1767 – 1782.

Wilairatana P., Tangpukdee N., Krudsood S., Wilairat N., Wilairat P., Thebpatipat P.  Overweight and obesity as protective factors in severe falciparum Malaria.  (2019) Southeast Asian Journal of Tropical Medicine and Public Health, 50 (3), pp. 421 – 427.

Iwagami M., Tangpukdee N., Wilairatana P., Krudsood S., Dao L.D., Nakazawa S., Sinuon M., Socheat D., Yasuoka J., Jimba M., Watanabe H., Kobayashi J., Toma H., Vanisaveth V., Hongvanthong B., Brey P.T., Kano S.  Pfcrt genotypes and related microsatellite DNA polymorphisms on Plasmodium falciparum differed among populations in the Greater Mekong Subregion.  (2018) Parasitology International, 67 (6), pp. 816 – 823

Adams P., Prakobtham S., Limpattaracharoen C., Suebtrakul S., Vutikes P., Khusmith S., Wilairatana P., Adams P., Kaewkungwal J.  Ethical issues of informed consent in malaria research proposals submitted to a research ethics committee in Thailand: A retrospective document review.  (2017) BMC Medical Ethics, 18 (1), art. no. 50.

Fukuda M.M., Krudsood S., Mohamed K., Green J.A., Warrasak S., Noedl H., Euswas A., Ittiverakul M., Buathong N., Sriwichai S., Miller R.S., Ohrt C.  A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.  (2017) PLoS ONE, 12 (11), art. no. e0187376

Maneerattanasak S., Gosi P., Krudsood S., Chimma P., Tongshoob J., Mahakunkijcharoen Y., Sukasem C., Imwong M., Snounou G., Khusmith S.  Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes.  (2017) Malaria Journal, 16 (1), art. no. 228

Dembele B.P.P., Chagan-Yasutan H., Niki T., Ashino Y., Tangpukdee N., Shinichi E., Krudsood S., Kano S., Hattori T.  Plasma levels of Galectin-9 reflect disease severity in malaria infection.  (2016) Malaria Journal, 15 (1), art. no. 403

Hahn W.O., Harju-Baker S., Erdman L.K., Krudsood S., Kain K.C., Wurfel M.M., Liles W.C.  A common TLR1 polymorphism is associated with higher parasitaemia in a Southeast Asian population with Plasmodium falciparum malaria.  (2016) Malaria Journal, 15 (1), art. no. 12

Kumsiri R., Troye-Blomberg M., Pattanapanyasat K., Krudsood S., Maneerat Y.  IgE low affinity receptor (CD23) expression, Plasmodium falciparum specific IgE and tumor necrosis factor-alpha production in Thai uncomplicated and severe falciparum malaria patients.  (2016) Acta Tropica, 154, pp. 25 – 33.

Maneerattanasak S., Gosi P., Krudsood S., Tongshoob J., Lanteri C.A., Snounou G., Khusmith S.  Genetic diversity among Plasmodium vivax isolates along the Thai-Myanmar border of Thailand.  (2016) Malaria Journal, 15 (1), art. no. 75

St Jean P.L., Xue Z., Carter N., Koh G.C.K.W., Duparc S., Taylor M., Beaumont C., Llanos-Cuentas A., Rueangweerayut R., Krudsood S., Green J.A., Rubio J.P.  Tafenoquine treatment of Plasmodium vivax malaria: Suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.  (2016) Malaria Journal, 15 (1), art. no. 97

Subramony H., Tangpukdee N., Krudsood S., Poovorawan K., Muangnoicharoen S., Wilairatana P.  Evaluation of efficacy of chloroquine for Plasmodium vivax infection using parasite clearance times: A 10-year study and systematic review.  (2016) Annals of the Academy of Medicine Singapore, 45 (7), pp. 303 – 314.

Toure O.A., Valecha N., Tshefu A.K., Thompson R., Krudsood S., Gaye O., Rao B.H.K., Sagara I., Bose T.K., Mohanty S., Rao B.S., Anvikar A.R., Mwapasa V., Noedl H., Arora S., Roy A., Iyer S.S., Sharma P., Saha N., Jalali R.K., Aristide C.M.A., Tiacoh L., Enosse S., Tangpukdee N., Kokolomami J., Ndiaye J.-L., Rao D., Yumva N.N., Sidibe B., Mohanty R., Jha A.C., Nyirenda M., Starzengruber P., Swoboda P.  A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.  (2016) Clinical Infectious Diseases, 62 (8), pp. 964 – 971

Adams P., Prakobtham S., Limphattharacharoen C., Vutikes P., Khusmith S., Pengsaa K., Wilairatana P., Kaewkungwal J.  Ethical considerations in malaria research proposal review: Empirical evidence from 114 proposals submitted to an Ethics Committee in Thailand.  (2015) Malaria Journal, 14 (1), art. no. 342.

Beck H.-P., Wampfler R., Carter N., Koh G., Osorio L., Rueangweerayut R., Krudsood S., Lacerda M.V., Llanos-Cuentas A., Duparc S., Rubio J.P., Green J.A.  Estimation of the antirelapse efficacy of tafenoquine, using plasmodium vivax genotyping.  (2015) Journal of Infectious Diseases, 212 (11), pp. 794 – 799

Kittitrakul C., Silachamroon U., Phumratanaprapin W., Krudsood S., Wilairatana P., Treeprasertsuk S.  Liver function tests abnormality and clinical severity of dengue infection in adult patients.  (2015) Journal of the Medical Association of Thailand, 98, pp. S1 – S8

Osorio L., Carter N., Arthur P., Bancone G., Gopalan S., Gupta S.K., Noedl H., Kochar S.K., Kochar D.K., Krudsood S., Lacerda M.V., Llanos-Cuentas A., Rueangweerayut R., Srinivasan R., Treiber M., Möhrle J.J., Green J.  Performance of binaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects.  (2015) American Journal of Tropical Medicine and Hygiene, 92 (1), pp. 22 – 27.

Thonsranoi K., Glaharn S., Punsawad C., Chaisri U., Krudsood S., Viriyavejakul P.  Increased synapsin I expression in cerebral malaria.  (2015) International Journal of Clinical and Experimental Pathology, 8 (11), pp. 13996 – 14004